These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2971 related articles for article (PubMed ID: 17296351)

  • 81. National Oncology Forum: perspectives for the year 2000.
    DeVita VT; Bleickardt EW
    Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Personalized medicine for the management of benign prostatic hyperplasia.
    Bechis SK; Otsetov AG; Ge R; Olumi AF
    J Urol; 2014 Jul; 192(1):16-23. PubMed ID: 24582540
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer.
    Schayek H; Bentov I; Jacob-Hirsch J; Yeung C; Khanna C; Helman LJ; Plymate SR; Werner H
    Horm Metab Res; 2012 Jun; 44(7):511-9. PubMed ID: 22495974
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Epigenetic markers of prostate cancer in plasma circulating DNA.
    Cortese R; Kwan A; Lalonde E; Bryzgunova O; Bondar A; Wu Y; Gordevicius J; Park M; Oh G; Kaminsky Z; Tverkuviene J; Laurinavicius A; Jankevicius F; Sendorek DH; Haider S; Wang SC; Jarmalaite S; Laktionov P; Boutros PC; Petronis A
    Hum Mol Genet; 2012 Aug; 21(16):3619-31. PubMed ID: 22619380
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [DNA methylation: an epigenetic process of medical importance].
    Rodríguez-Dorantes M; Téllez-Ascencio N; Cerbón MA; López M; Cervantes A
    Rev Invest Clin; 2004; 56(1):56-71. PubMed ID: 15144044
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Acute myeloid leukemia: therapeutic impact of epigenetic drugs.
    Altucci L; Clarke N; Nebbioso A; Scognamiglio A; Gronemeyer H
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1752-62. PubMed ID: 15964234
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas.
    Singh AP; Chauhan SC; Bafna S; Johansson SL; Smith LM; Moniaux N; Lin MF; Batra SK
    Prostate; 2006 Mar; 66(4):421-9. PubMed ID: 16302265
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Recursive causality in evolution: a model for epigenetic mechanisms in cancer development.
    Haslberger A; Varga F; Karlic H
    Med Hypotheses; 2006; 67(6):1448-54. PubMed ID: 16844314
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.
    Luo J; Dunn TA; Ewing CM; Walsh PC; Isaacs WB
    Prostate; 2003 Oct; 57(2):134-9. PubMed ID: 12949937
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Targeting epigenetic abnormalities with histone deacetylase inhibitors.
    Conley BA; Wright JJ; Kummar S
    Cancer; 2006 Aug; 107(4):832-40. PubMed ID: 16826577
    [TBL] [Abstract][Full Text] [Related]  

  • 92. DNA methylation and mammalian epigenetics.
    Reik W; Dean W
    Electrophoresis; 2001 Aug; 22(14):2838-43. PubMed ID: 11565778
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Molecular biology of prostate cancer progression.
    Isaacs WB; Bova GS; Morton RA; Bussemakers MJ; Brooks JD; Ewing CM
    Cancer Surv; 1995; 23():19-32. PubMed ID: 7621457
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer.
    Kim SJ; Kelly WK; Fu A; Haines K; Hoffman A; Zheng T; Zhu Y
    Cancer Lett; 2011 Mar; 302(1):47-53. PubMed ID: 21237555
    [TBL] [Abstract][Full Text] [Related]  

  • 95. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
    Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Alterations in epigenetic modifications during oocyte growth in mice.
    Kageyama S; Liu H; Kaneko N; Ooga M; Nagata M; Aoki F
    Reproduction; 2007 Jan; 133(1):85-94. PubMed ID: 17244735
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Epigenetic tools in potential anticancer therapy.
    Sebova K; Fridrichova I
    Anticancer Drugs; 2010 Jul; 21(6):565-77. PubMed ID: 20436342
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Epigenetics--an epicenter of gene regulation: histones and histone-modifying enzymes.
    Biel M; Wascholowski V; Giannis A
    Angew Chem Int Ed Engl; 2005 May; 44(21):3186-216. PubMed ID: 15898057
    [TBL] [Abstract][Full Text] [Related]  

  • 99. DNA methylation in urological malignancies (review).
    Schulz WA
    Int J Oncol; 1998 Jul; 13(1):151-67. PubMed ID: 9625817
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors.
    Herceg Z
    Mutagenesis; 2007 Mar; 22(2):91-103. PubMed ID: 17284773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 149.